Cargando…

Complete Response of Triple-Negative Metaplastic Carcinoma of the Breast Using Pembrolizumab

Metaplastic breast cancer (MpBC) is a rare form of breast malignancy with a poor prognosis and limited treatment guidance. Here, we report on a case of triple-negative MpBC that was successfully treated following the Keynote-522 clinical algorithm using pembrolizumab, paclitaxel, carboplatin, adriam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ladwa, Amrita, Elghawy, Omar, Schroen, Anneke, Abernathy, Kristan, Schlefman, Jenna, Dillon, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601781/ https://www.ncbi.nlm.nih.gov/pubmed/37900847 http://dx.doi.org/10.1159/000534146

Ejemplares similares

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015)

Clinical value of R-spondins in triple-negative and metaplastic breast cancers
por: Coussy, F, et al.
Publicado: (2017)

Comparison of outcomes between metaplastic and triple-negative breast cancer patients
por: Polamraju, Praveen, et al.
Publicado: (2019)

Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors
por: Djomehri, Sabra I., et al.
Publicado: (2020)

Prognostic Factor Analysis and Model Construction of Triple-Negative Metaplastic Breast Carcinoma After Surgery
por: Zhu, Keying, et al.
Publicado: (2022)

Fibromatosis-Like Metaplastic Carcinoma: A Triple-Negative Breast Cancer with Clinically Indolent Behavior
por: Pham, Khoa Hong, et al.
Publicado: (2022)

Nomogram for the prediction of triple-negative breast cancer histological heterogeneity based on multiparameter MRI features: A preliminary study including metaplastic carcinoma and non- metaplastic carcinoma
por: Kong, Qing-cong, et al.
Publicado: (2022)

Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
por: Gorshein, Elan, et al.
Publicado: (2021)

Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
por: Mao, Jinqian, et al.
Publicado: (2021)

Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome
por: Munawar, Shahzeb, et al.
Publicado: (2021)

Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis
por: Yang, Xiaolu, et al.
Publicado: (2023)

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
por: Lien, Huang-Chun, et al.
Publicado: (2023)

Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient
por: Rossi, Tania, et al.
Publicado: (2021)

Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient
por: Vannini, Ivan, et al.
Publicado: (2022)

Metaplastic carcinoma of the breast: an immunohistochemical study
por: Altaf, Fadwa J, et al.
Publicado: (2014)

Human Metaplastic Breast Carcinoma and Decorin
por: Boström, Pia, et al.
Publicado: (2017)

Differences of Clinicopathological Features between Metaplastic Breast Carcinoma and Nonspecific Invasive Breast Carcinoma and Prognostic Profile of Metaplastic Breast Carcinoma
por: Qiu, Yue, et al.
Publicado: (2022)

Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
por: Marhold, Maximilian, et al.
Publicado: (2023)

Mutant Phenotype p53 Immunohistochemical Expression Is Associated With Poor Prognostic Parameters and Disease-Free Survival in Triple-Negative Metaplastic Breast Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2021)

Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab
por: Bagegni, Nusayba A, et al.
Publicado: (2022)

Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast Cancer
por: Jacobson, Anne
Publicado: (2022)

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Takahashi, Masato, et al.
Publicado: (2023)

Metaplastic Carcinoma of the Breast with Neuroectodermal Stromal Component
por: Tot, Tibor, et al.
Publicado: (2011)

Metaplastic Carcinoma with Predominant Chondrosarcoma of the Right Breast
por: Bhosale, S.J., et al.
Publicado: (2010)

Diagnostic utility of snail in metaplastic breast carcinoma
por: Nassar, Aziza, et al.
Publicado: (2010)

Metaplastic carcinoma of the breast with rhabdo-myosarcomatous element
por: Anand, Mani, et al.
Publicado: (2014)

Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast
por: Piscuoglio, Salvatore, et al.
Publicado: (2017)

Hypercalcemia in Metaplastic Squamous Cell Carcinoma of the Breast
por: Hardy, Brendan M., et al.
Publicado: (2019)

Metaplastic breast carcinoma with upper limb gangrene
por: Rajan, Reynu, et al.
Publicado: (2017)

Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast
por: Xiao, Meng, et al.
Publicado: (2017)

Metaplastic breast carcinoma with extensive osseous differentiation
por: Khade, Shalaka, et al.
Publicado: (2021)

Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review
por: Wu, Jing, et al.
Publicado: (2023)

Estrogen receptor status has no prognostic relevance in metaplastic breast carcinoma
por: Abada, Evi, et al.
Publicado: (2022)

Pembrolizumab plus chemotherapy in Japanese patients with triple‐negative breast cancer: Results from KEYNOTE‐355
por: Hattori, Masaya, et al.
Publicado: (2023)

Imaging Findings of Metaplastic Carcinoma of the Breast with Pathologic Correlation
por: Donato, Henrique, et al.
Publicado: (2018)

Metaplastic Breast Carcinoma in the Lungs: A Case Report
por: Bourdeanu, Laura, et al.
Publicado: (2013)

Metaplastic carcinoma of breast: a report of two cases
por: Yahaya, James, et al.
Publicado: (2020)

Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile
por: Haroon, Saroona, et al.
Publicado: (2021)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Wong, Willard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8vmllb5ukuoapuastkj04n0276